Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays.
Sojeong YunJi Hyeong RyuJoo Hee JangHyunjoo BaeSeung-Hyo YooAe Ran ChoiSung Jin JoJihyang LimJehoon LeeHyejin RyuSung-Yeon ChoDong-Gun LeeJongmin LeeSeok-Chan KimYeon Joon ParkHyeyoung LeeEun Jee OhPublished in: Annals of laboratory medicine (2021)
Positivity rates and seroconversion of SARS-CoV-2 antibodies vary depending on the assay kits, disease severity, and antigen target. This study contributes to a better understanding of antibody response in symptomatic COVID-19 patients using currently available assays.